Company Filing History:
5 out of 155 
1 out of 2 
1 out of 1 Years Active: 2015-2023
Title: **Inventor Henri-Jacques Delecluse: Pioneering Advancements in Vaccination Technology**
Introduction
Henri-Jacques Delecluse is a notable inventor based in Heidelberg, Germany, recognized for his significant contributions to the field of virology and immunology. With a total of six patents to his name, his innovations are primarily focused on improving vaccination methods against the Epstein-Barr virus (EBV).
Latest Patents
Among his latest patents, Delecluse has developed groundbreaking technologies related to Epstein-Barr virus-like particles (EB-VLPs). One of his patents describes a preparation which includes EB-VLPs that are predominantly free of Epstein-Barr virus DNA. This preparation incorporates a vaccination polypeptide containing at least one peptide from an EBV tegument polypeptide, along with an immunogenic peptide.
Another essential patent focuses on creating a composition of EBV particles aimed at the vaccination of subjects. This innovation features a significantly reduced chromosome instability-inducing activity of EBV polypeptides. Additionally, it details methods to prevent these particles from contacting the cytosol and nucleus of cells to enhance vaccine safety and efficacy.
Career Highlights
Delecluse's illustrious career has been marked by his affiliation with prestigious research institutions. He has worked at the German Cancer Research Center (Deutsches Krebsforschungszentrum) and Helmholtz Zentrum München, which is part of the German Research Center for Environmental Health (GmbH). These institutions have provided him with a platform to advance his research on viral immunology.
Collaborations
Throughout his career, Henri-Jacques Delecluse has collaborated with prominent colleagues, including Regina Feederle and Emmalene Bartlett. These partnerships have enabled him to enhance the scope of his research and contribute to noteworthy advancements in vaccine development.
Conclusion
Henri-Jacques Delecluse continues to make significant strides in the field of vaccination technology through his innovative patents and collaborations. With his ongoing research, he is paving the way for more effective vaccines that may one day change the landscape of infectious disease prevention, particularly concerning the Epstein-Barr virus. His contributions exemplify the impact of dedicated inventors in advancing public health.